Surgical and medical therapy for pancreatic carcinoma
- 1 June 2002
- journal article
- review article
- Published by Elsevier in Best Practice & Research Clinical Gastroenterology
- Vol. 16 (3) , 435-455
- https://doi.org/10.1053/bega.2002.0317
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- The role of adjuvant therapy for pancreatic cancerExpert Opinion on Investigational Drugs, 2002
- Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled TrialAnnals of Surgery, 2001
- Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trialThe Lancet, 2001
- Cancer burden in the year 2000. The global picturePublished by Elsevier ,2001
- Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implicationsSurgical Oncology, 2001
- Rates of Complications and Death After Pancreaticoduodenectomy: Risk Factors and the Impact of Hospital VolumeAnnals of Surgery, 2000
- Relationship between hospital volume and late survival after pancreaticoduodenectomySurgery, 1999
- Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic unitsBritish Journal of Surgery, 1997
- Treatment and survival in 13560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological studyBritish Journal of Surgery, 1995
- Survival After PancreatoduodenectomyAnnals of Surgery, 1990